INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2015
Net Assets |
£263m |
Net Assets per share |
648p |
Share price |
582p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
101 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
8.1 |
Gilead |
7.7 |
Amgen |
7.6 |
Regeneron |
6.8 |
Biogen |
5.7 |
Alexion |
4.3 |
Vertex |
3.7 |
Chimerix |
3.1 |
Biomarin |
3.0 |
Ophthotech |
2.6 |
|
----------- |
Total |
52.6 |
Portfolio Profitability |
% NAV |
Profitable |
54 |
Turning Profitable 2015 |
8 |
Unprofitable |
38 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
84 |
Europe & UK |
16 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
93 |
Unquoted |
7 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
28 AUGUST 2015